Cracking the diversity of sweet drugs

Sharon Yehuda,Vered Padler-Karavani
DOI: https://doi.org/10.1038/s41589-024-01755-6
IF: 14.8
2024-10-25
Nature Chemical Biology
Abstract:Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.
biochemistry & molecular biology
What problem does this paper attempt to address?